Phase 2 Multicenter Study Of Tazemetostat, An Ezh2 Inhibitor, In Patients With Relapsed Or Refractory Follicular Lymphoma
Franck Morschhauser,Herve Tilly,Aristeidis Chaidos,Tycel J. Phillips,Vincent Ribrag,Philip Campbell,Damaj Gandhi Laurent,Wojciech Jurczak,Pamela McKay,Stephen Opat,John Radford,Jennifer Whalen,Anand Rajarethinam, Susan Benedict Navia,Deyaa Adib,Gilles Salles BLOOD（2019）
AI 理解论文
溯源树
样例
